Eton Pharmaceuticals' ET-600 met bioequivalence standards in a study, with an FDA filing planned for April 2025 and a ...

Syndax Pharmaceuticals Inc (SNDX) reports promising revenue from Revv Forge launch and outlines strategic growth plans, ...

Company’s patented desmopressin oral solution successfully passed pivotal bioequivalence study -- Company expects to submit ...

A big dampener to Lupin’s plans would be the potential imposition of tariff on pharma products by the Trump government.

Rajeev Juneja, vice chairman and managing director of Mumbai, Indian-based drugmaker Mankind Pharma (NSE: MANKIND), today ...

Mankind Pharma has launched generic versions of diabetes medication Empagliflozin under brand names Empaglyde, Empagreat, and ...

Mankind Pharma and other domestic companies have launched generic versions of the popular diabetes drug Empagliflozin at ...

Glenmark Pharmaceuticals has announced the launch of 'Polyethylene Glycol 3350 Powder for Solution' as on OTC product in the US market.

Launching new pharmaceutical products has never been simple, with marketers well aware that a poorly planned and executed initial launch for a new product makes it very hard to be successful in ...